JVI Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Britt, W. J.
Right arrow Articles by Mach, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Britt, W. J.
Right arrow Articles by Mach, M.

 Previous Article  |  Next Article 

Journal of Virology, April 2005, p. 4066-4079, Vol. 79, No. 7
0022-538X/05/$08.00+0     doi:10.1128/JVI.79.7.4066-4079.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Antigenic Domain 1 Is Required for Oligomerization of Human Cytomegalovirus Glycoprotein B

William J. Britt,1,2,3* Michael A. Jarvis,4 Derek D. Drummond,4 and Michael Mach5

Departments of Pediatrics,1 Microbiology,2 Neurobiology, University of Alabama School of Medicine, Birmingham, Alabama,3 Vaccine and Gene Therapy Institute, Oregon Health Sciences University, Portland, Oregon,4 Institut für Klinische und Molekulare Virologie, Universität Erlangen-Nürnberg, Erlangen, Germany5

Received 8 September 2004/ Accepted 4 November 2004

Human cytomegalovirus (HCMV) glycoprotein B (gB) is an abundant virion envelope protein that has been shown to be essential for the infectivity of HCMV. HCMV gB is also one of the most immunogenic virus-encoded proteins, and a significant fraction of virus neutralizing antibodies are directed at gB. A linear domain of gB designated AD-1 (antigenic domain 1) represents a dominant antibody binding site on this protein. AD-1 from clinical isolates of HCMV exhibits little sequence variation, suggesting that AD-1 plays an essential role in gB structure or function. We investigated this possibility by examining the role of AD-1 in early steps of gB synthesis. Our results from studies using eukaryotic cells indicated that amino acid (aa) 635 of the gB sequence represented the carboxyl-terminal limit of this domain and that deletion of aa 560 to 640 of the gB sequence resulted in loss of AD-1 expression. AD-1 was shown to be required for oligomerization of gB. Mutation of cysteine at either position 573 or 610 in AD-1 resulted in loss of its reactivity with AD-1-specific monoclonal antibodies and gB oligomerization. Infectious virus could not be recovered from HCMV bacterial artificial chromosomes following introduction of these mutations into the HCMV genome, suggesting that AD-1 was an essential structural domain required for gB function in the replicative cycle of HCMV. Sequence alignment of AD-1 with homologous regions of gBs from other herpesviruses demonstrated significant relatedness, raising the possibility that this domain may contribute to multimerization of gBs in other herpesviruses.


* Corresponding author. Mailing address: Department of Pediatrics, Room 107, Harbor Bldg., Childrens Hospital, University of Alabama School of Medicine, Birmingham, AL 35294. Phone: (205) 996-7782. Fax: (205) 975-6549. E-mail: wbritt{at}peds.uab.edu.


Journal of Virology, April 2005, p. 4066-4079, Vol. 79, No. 7
0022-538X/05/$08.00+0     doi:10.1128/JVI.79.7.4066-4079.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
J. Bacteriol. Mol. Cell. Biol. Microbiol. Mol. Biol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2005 by the American Society for Microbiology. All rights reserved.